Rocket


News + Filings
Transactions



GORDON CARL L

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
08/14/2023Adicet Bio, Inc.TORCDispositionStock Option (Right to Buy)30k$16.11$483.3k 08/14/2023
08/14/2023Adicet Bio, Inc.TORCGrantStock Option (Right to Buy)30k$0.00$0 08/14/2023
08/14/2023Adicet Bio, Inc.TORCDispositionStock Option (Right to Buy)18.5k$15.93$294.7k 08/14/2023
08/14/2023Adicet Bio, Inc.TORCGrantStock Option (Right to Buy)18.5k$0.00$0 08/14/2023
08/14/2023Adicet Bio, Inc.TORCDispositionStock Option (Right to Buy)18.5k$11.49$212.6k 08/14/2023
08/14/2023Adicet Bio, Inc.TORCDispositionStock Option (Right to Buy)26.4k$5.20$137.1k 08/14/2023
08/14/2023Adicet Bio, Inc.TORCGrantStock Option (Right to Buy)26.4k$0.00$0 08/14/2023
07/17/2023Theseus Pharmaceuticals, Inc.THRXPurchaseCommon Stock328.5k$3.05$1MSee Footnotes07/17/2023
07/17/2023Theseus Pharmaceuticals, Inc.THRXPurchaseCommon Stock151.4k$3.05$461.9kSee Footnotes07/17/2023
06/27/2023Adicet Bio, Inc.TORCPurchaseCommon Stock58k$2.09$121.2kSee footnotes06/27/2023
06/27/2023Adicet Bio, Inc.TORCPurchaseCommon Stock442k$2.09$923.8kSee footnotes06/27/2023
06/27/2023Adicet Bio, Inc.TORCPurchaseCommon Stock250k$2.09$522.5kSee footnotes06/27/2023
06/27/2023Adicet Bio, Inc.TORCPurchaseCommon Stock125k$2.09$261.2kSee footnotes06/27/2023
06/06/2023Keros Therapeutics, Inc.KROSGrantStock Option (right to buy)10k$48.79$487.9k 06/06/2023
06/01/2023Adicet Bio, Inc.TORCGrantCommon Stock5.9k$0.00$0 06/01/2023
06/01/2023Adicet Bio, Inc.TORCGrantStock Option (Right to Buy)26.4k$5.20$137.1k 06/01/2023
05/05/2023Kinnate Biopharma Inc. PurchaseCommon Stock490.5k$2.82$1.4MSee footnotes05/04/2023
05/05/2023Kinnate Biopharma Inc. PurchaseCommon Stock490.5k$2.82$1.4MSee footnotes05/04/2023
05/04/2023Kinnate Biopharma Inc. PurchaseCommon Stock83.5k$2.75$229.5kSee footnotes05/04/2023
05/04/2023Kinnate Biopharma Inc. PurchaseCommon Stock313k$2.75$860.7kSee footnotes05/04/2023
05/04/2023Kinnate Biopharma Inc. PurchaseCommon Stock83.5k$2.75$229.5kSee footnotes05/04/2023
05/02/2023Kinnate Biopharma Inc. PurchaseCommon Stock58.8k$2.67$157.1kSee footnotes04/28/2023
05/02/2023Kinnate Biopharma Inc. PurchaseCommon Stock220.6k$2.67$589kSee footnotes04/28/2023
05/02/2023Kinnate Biopharma Inc. PurchaseCommon Stock58.8k$2.67$157.1kSee footnotes04/28/2023
05/01/2023Kinnate Biopharma Inc. PurchaseCommon Stock124.5k$2.62$326.3kSee footnotes04/28/2023
05/01/2023Kinnate Biopharma Inc. PurchaseCommon Stock467.1k$2.62$1.2MSee footnotes04/28/2023
05/01/2023Kinnate Biopharma Inc. PurchaseCommon Stock124.5k$2.62$326.3kSee footnotes04/28/2023
04/28/2023Kinnate Biopharma Inc. PurchaseCommon Stock61k$2.55$155.5kSee footnotes04/28/2023
04/28/2023Kinnate Biopharma Inc. PurchaseCommon Stock228.8k$2.55$583.3kSee footnotes04/28/2023
04/28/2023Kinnate Biopharma Inc. PurchaseCommon Stock61k$2.55$155.5kSee footnotes04/28/2023
02/17/2023Kinnate Biopharma Inc. GrantCommon Stock550k$0.00$0See footnotes02/17/2023
02/17/2023Kinnate Biopharma Inc. GrantCommon Stock550k$0.00$0See footnotes02/17/2023
02/08/2023Compass Therapeutics, Inc.CMPXGrantStock Option (Right to Buy)60k$3.93$235.8k 02/08/2023
12/23/2022Terns Pharmaceuticals, Inc. PurchaseCommon Stock137.9k$7.25$1000kSee footnotes12/23/2022
11/08/2022Compass Therapeutics, Inc.CMPXPurchaseCommon Stock402k$3.21$1.3MSee Footnotes11/08/2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy